Historical record - last NADAC effective date: 2/22/2017
Product Information
IRBESARTAN 300 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2702 per EA under NDC 65862063930. Its NADAC has been published 170 times since Nov 28, 2013.
FDA first approved this application on Sep 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862063930
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203081FDA Approved
9/27/2012
TE Code
AB
On Market Since
9/27/2012
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 300 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 22.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2702 per EA |
|---|---|
| All-time high | $0.3709 (Mar 12, 2014) |
| All-time low | $0.2650 (Nov 18, 2015) |
| Median price | $0.3167 |
| Average price | $0.3189 |
| Largest weekly change | +18.2% (Dec 23, 2015) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-22.9%
Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IRBESARTAN 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 300 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2702 per EA (NDC 65862063930), effective Feb 22, 2017.
How has the price of IRBESARTAN 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 300 MG TABLET has declined 22.9%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 300 MG TABLET?
Since Nov 28, 2013, the NADAC for IRBESARTAN 300 MG TABLET has ranged from a low of $0.2650 (Nov 18, 2015) to a high of $0.3709 (Mar 12, 2014), with a median of $0.3167 per EA.
Are there cheaper alternatives to IRBESARTAN 300 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IRBESARTAN 300 MG TABLET, is $0.1555 per EA — about 42% below IRBESARTAN 300 MG TABLET.
Who manufactures IRBESARTAN 300 MG TABLET?
IRBESARTAN 300 MG TABLET (NDC 65862063930) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.